drugset

drugset / Trial / NCT05911503

Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

NCT05911503 ↗

Phase 0 Recruiting 15 enrolled Tianjin Medical University

NaSingle-groupOpen-labelTreatment

Summary

Clinical study of high concentration ganciclovir eye drops in the treatment of cytomegalovirus retinitis

Timeline

Start: 2023-07-01
Primary completion: 2027-06-01
Completion: 2027-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ganciclovir	Small molecule	2 %	Other

Indications